Literature DB >> 3871667

Human interleukin 1 mediates cartilage matrix degradation.

T Krakauer, J J Oppenheim, H E Jasin.   

Abstract

Human monocyte factors mediate cartilage matrix degradation by activation of the resident chondrocytes. In the present work, the cartilage matrix-degrading activity of partially purified human monocyte-derived interleukin 1 has been investigated. Human monocyte or blood mononuclear cell culture supernatants were sequentially purified by phenyl-Sepharose and gel filtration chromatography, or by gel filtration chromatography, isoelectric focusing, or chromatofocusing. Column fractions were simultaneously tested by the standard method that defines interleukin 1 activity--costimulation of mouse thymocyte proliferation--and for matrix macromolecule release from living bovine cartilage explants in organ culture. The two activities showed identical profiles in purification steps that would discriminate according to molecular size, hydrophobicity, and net charge. Moreover, the thermal denaturation profiles of the material purified by chromatofocusing could not distinguish between thymocyte proliferating and matrix degrading activities. These results suggest that interleukin 1 which is present in inflammatory synovial fluids may play an important role in the mediation of cartilage damage in chronic inflammatory arthritides.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871667     DOI: 10.1016/0008-8749(85)90034-6

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  22 in total

1.  Biological characterization of interleukin-1-like cytokine produced by cultured bone cells from newborn mouse calvaria.

Authors:  S Hanazawa; S Amano; K Nakada; Y Ohmori; T Miyoshi; K Hirose; S Kitano
Journal:  Calcif Tissue Int       Date:  1987-07       Impact factor: 4.333

Review 2.  Cytokine-mediated proteolysis in tissue remodelling.

Authors:  S Masure; G Opdenakker
Journal:  Experientia       Date:  1989-06-15

3.  Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines.

Authors:  J A Tyler
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

4.  Differential effects of interleukin-1 and transforming growth factor beta on the synthesis of small proteoglycans by rabbit articular chondrocytes cultured in alginate beads as compared to monolayers.

Authors:  M Demoor-Fossard; M Boittin; F Redini; J P Pujol
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

5.  Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study.

Authors:  W B van den Berg; F A van de Loo; W A Zwarts; I G Otterness
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

6.  Recombinant human interleukin-1 alpha and recombinant human interleukin-1 beta stimulate cartilage matrix degradation and inhibit glycosaminoglycan synthesis.

Authors:  R J Smith; N A Rohloff; L M Sam; J M Justen; M R Deibel; J C Cornette
Journal:  Inflammation       Date:  1989-08       Impact factor: 4.092

7.  Fimbriated Porphyromonas gingivalis is more efficient than fimbria-deficient P. gingivalis in entering human dendritic cells in vitro and induces an inflammatory Th1 effector response.

Authors:  Ravi Jotwani; Christopher W Cutler
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Presentation of cartilage proteoglycan to a T cell hybridoma derived from a mouse with proteoglycan-induced arthritis.

Authors:  F R Brennan; G Negroiu; E I Buzás; C Fülöp; K Holló; K Mikecz; T T Glant
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

9.  Proteoglycan biosynthesis by rabbit articular chondrocytes treated with D-penicillamine.

Authors:  P Legendre; M Bouakka; M Langris; J P Pujol; R Beliard; G Loyau; J Bocquet
Journal:  Agents Actions       Date:  1988-08

10.  Interleukin 1 mediated acceleration of type II collagen-induced arthritis: effects of anti-inflammatory or anti-arthritic drugs.

Authors:  J T Hom; V L Gliszczynski; H W Cole; A M Bendele
Journal:  Agents Actions       Date:  1991-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.